In accordance with these results, M2 has been found to result in poor response of chemotherapy [20], and increased infiltration of activated memory CD4 in ESCC patients with chemoradiotherapy was a favorable indicator of ESCC prognosis [21]. This evidence concerns the gene CD4 and esophageal squamous cell carcinoma.